Coya Therapeutics, Inc. (COYA) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$10.74M | -4.4% |
| 2024 | -$10.29M | +8.0% |
| 2023 | -$11.19M | -54.6% |
| 2022 | -$7.24M | -85.5% |
| 2021 | -$3.90M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$10.74M | -4.4% |
| 2024 | -$10.29M | +8.0% |
| 2023 | -$11.19M | -54.6% |
| 2022 | -$7.24M | -85.5% |
| 2021 | -$3.90M | — |